Oneview Healthcare Launches World’s First Cloud-based Care Experience Platform

|

Published 01-APR-2021 10:39 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Yesterday, Oneview Healthcare (ASX:ONE) announced the launch of CXP Cloud Enterprise, the world’s first and only cloud-based care experience platform. Deploying Microsoft Azure technology, this platform makes it easier for health systems to support personalised, whole person care.

CXP Cloud Enterprise enables health systems to quickly adopt technology for engaging patients, reducing non-clinical demands on care teams and optimising clinical and operational effectiveness. This comes at a critical time to meet the demand for digital services driven by the pandemic.

“The cloud-based platform is a key pillar of our growth strategy,” said James Fitter, Chief Executive Officer for Oneview.

“Being the first and only cloud-based care experience solution gives us a strong competitive advantage and means health systems can rapidly implement the capabilities that meet their needs today while providing the agility, scalability and investment protection to grow as their health system changes. We are excited to know that CXP Cloud Enterprise will help transform the hospital experience for patients, families and care teams.”

“The cloud enablement of Oneview's patient experience platform is a game changer.” added Dr Simon Kos, Healthcare Industry Executive, Microsoft Australia.

“It means that health organisations can deploy more quickly, with greater predictability and less specialised resources, all on the trusted Azure cloud. This is a win for patients, clinicians and healthcare organisations that put patient experience and outcomes first.”

About CXP Cloud Enterprise

The CXP Cloud Enterprise platform was developed in partnership with NYU Langone Health, a leading academic medical centre in New York, who rapidly rolled out the virtual engagement platform across their facilities during the COVID-19 pandemic to address the increased pressure on care teams and patient’s restricted access to family and friends.

Together, NYU Langone and Oneview collaborated on the initial cloud-based version that enabled NYU Langone to implement key capabilities across 400 beds in just weeks.

Yesterday's introduction of CXP Cloud Enterprise delivers the full functionality and integration capabilities of the care experience platform in a faster, easier, more affordable cloud model at the bedside.

Oneview’s CXP Cloud Enterprise

Oneview’s CXP Cloud Enterprise provides full functionality on a secure, reliable cloud deployment with patient education, meal ordering, patient service requests, apps and digital services, virtual rounding, visitation, and translation services. This comprehensive platform can drive more meaningful engagement, improved satisfaction and provides better control and quality of care for both patients and care providers.

Key features now available with cloud deployments include:

  • Bedside telehealth consultations from offsite care team members
  • Rounding questionnaires and a digital work list
  • Clinician screen-casting to help patients understand their condition, treatment and goals
  • Automated service requests help nurses reduce call button distractions
  • Targeted patient educational resources
  • Meal ordering customised for their dietary needs
  • On-demand entertainment
  • Video chat to connect with friends and family
  • Simple integration with current systems for a single, secure platform hosting the latest apps

About Oneview Healthcare

Oneview Healthcare is a global healthcare technology company listed on the Australian Securities Exchange.

For healthcare systems who lead on exemplary care, ONE provides digital tools for patients, families, and caregivers to improve the care experience.

Unifying a facility’s systems, content and services into one digital platform with dedicated devices at the point of care, Oneview helps deliver more control for patients and families, more time for care teams, and less complexity for executives and IT teams.

Oneview is proud to partner with leading healthcare systems in the US, Australia, the Middle East and Asia.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X